All Musculoskeletal and joints articles
-
On demand webinarsDisease-modifying anti-rheumatic drugs (DMARDS) guidelines: a focus on methotrexate guidance in clinical practice
Information intended for UK healthcare professionals only. This webinar was initiated and commissioned by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
View Methofill® (methotrexate) pre-filled injector and pre-filled syringe prescribing information and adverse event reporting information here
View the Summary of Product Characteristics for Folic Acid 5mg Tablets; Legal Cat POM; NHS List price 90p
UK-02645
Date of preparation: September 2021 -
Supplement
The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document
Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d Date of preparation: August 2021 -
Supplement
Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*
Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021 -
Medicines appraisal cards
Romosozumab▼ (Evenity®) 105mg solution for injection in prefilled pen SMC2280
The production of this Guidelines card has been commissioned by UCB Pharma Ltd.
Amgen and UCB Pharma Ltd are co-developing Evenity®.
View prescribing information and adverse event reporting
UK-P-RM-OP-2000095 December 2020 -
Implementing guidelines
Osteoporosis: assessing and managing patients at low, high, and very high risk
Dr David Stephens introduces a consensus guideline to assist primary care in the assessment, management, and treatment of osteoporosis
-
Implementing guidelines
Pregnancy and rheumatic diseases: best practice and prescribing considerations
Professor Ian Giles and Professor Caroline Gordon describe best practice in the care of women of child-bearing age with inflammatory rheumatic diseases before, during, and after pregnancy
-
Top tips
Top tips: joint pain
Dr Louise Warburton offers 10 top tips on the diagnosis and management of joint pain in primary care
-
Implementing guidelines
Osteoporosis: target treatment on the basis of fracture risk
Dr David Stephens summarises new recommendations from the updated SIGN guideline on the management of osteoporosis and prevention of fragility fractures
-
Test and reflect
Patient scenarios: joint pain
The following case studies, written by Dr Louise Warburton, relate to her expert article, Top tips: joint pain.
-
Implementing guidelines
People with suspected rheumatoid arthritis must be referred urgently
Dr Louise Warburton reviews the latest recommendations from NICE on the management of rheumatoid arthritis in adults
-
Test and reflect
NICE guideline on rheumatoid arthritis
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on NICE guideline 100, Rheumatoid arthritis in adults: management .
-
News
Guideline on rheumatoid arthritis published by NICE
NICE has released NICE Guideline (NG) 100 on Rheumatoid arthritis in adults: management, which replaces Clinical Guideline 79.
-
Differential diagnoses
Low back pain: what’s the diagnosis?
Dr Simon Somerville considers some possible causes of low back pain and explains that self-management is key to improved quality of life for patients
-
Test and reflect
NOGG guideline on osteoporosis
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on preventing and treating osteoporosis in primary care—you will then be prompted to reflect on your learning.
-
Implementing guidelines
Fragility fractures: an integrated care network is needed
Dr Alun Cooper considers the impact fragility fractures have on individuals and UK health services and summarises recent NOGG recommendations on osteoporosis prevention and treatment
-
NICE quality standard article
Risk assessment and treatment are key in osteoporosis
Dr David Stephens offers an overview of the NICE quality standard on osteoporosis and discusses how to identify, assess, and manage people who may be at risk from fragility fracture
-
News
Update to BSR gout guideline published
The British Society for Rheumatology guideline for the management of gout has been updated.
-
News
NICE technology appraisal for psoriatic arthritis treatment published
NICE has published Technology Appraisal (TA) 445 on Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs, and a notice that TA444 has been terminated due to no evidence being submitted.
-
News
Guidance and quality standard on hip fracture updated by NICE
NICE has updated Clinical Guideline 124 on managing hip fracture and Quality Standard 16 on hip fracture in adults.
-
News
Quality standard on osteoporosis published by NICE
NICE has published Quality Standard 149 on Osteoporosis.
